| Name | Title | Contact Details |
|---|
ROX MEDICAL is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
NXC Imaging is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
When it comes to treating addiction to opioids and other substances, there`s no single magic bullet. Rather, it takes a combination of tools to surround patients with care and keep them on the road to recovery. Spero Health delivers outpatient care to treat patients close to home in their own environments so they can cope with life as they overcome addiction. We create an individualized treatment plan for each patient using a pioneering, proven, three-pronged approach: 1. Evidence-based physician services • Physician visit • Mental and physical health screenings • Individualized recovery plan • Medication-assisted treatment, which may include Suboxone® or Vivitrol, to ease the symptoms of withdrawal and craving for opioids 2. Counseling • Individual and/or group sessions that provide safe places to talk and valuable support to help patients achieve lasting recovery 3. Recovery Support Services • Assistance in finding employment, housing, healthcare, child care, legal services, transportation and more • Wellness programs, such as smoking cessation, sleep hygiene and nutrition • Education to help patients better understand their disorder and the steps toward a successful recovery
Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.